Skip to main content

Table 1 Surgical approaches and postoperative follow-ups of 16 cases of OSFTs

From: Factors for postoperative recurrence of orbital solitary fibrous tumor: an analysis of long‐term clinical follow‐up results from a Chinese tertiary hospital

Patient No./Sex Symptoms Side Treatment and Surgical Approach Tumor location and involvement Immuno-histochemistry Progress Prognosis Follow-up time, m
CD34 Ki-67
1/F Proptosis; Vision loss R Transorbital approach Inside the muscle cone;
lateral wall of the orbit;
+ +(<10 %) Improvement of the proptosis and vision Recurrence 120
Proptosis; Vision loss R Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Improvement of the proptosis and vision None recurrence 92
2/F Proptosis; Vision loss L Transorbital approach Inside the muscle cone;
lateral wall of the orbit;
+ +(< 10 %) Improvement of the proptosis and vision Recurrence 34
Proptosis; Vision loss L Transorbital approach Inside the muscle cone;
lateral wall of the orbit;
+ +(< 10 %) Improvement of the proptosis and vision Recurrence 28
Proptosis; Vision loss L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Improvement of the proptosis and vision None recurrence 24
3/M Proptosis; Visual field defect; Ocular movement disorder L Transorbital approach Inside the muscle cone + +(< 10 %) Improvement of the proptosis Recurrence 18
Proptosis; Visual field defect; Ocular movement disorder L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
+ +(< 10 %) Improvement of the proptosis None recurrence 24
4/M Proptosis; Vision loss R Transorbital approach Inside the muscle cone;
lateral wall of the orbit
+ +(< 10 %) Improvement of the proptosis Recurrence 24
Proptosis; Blindness R Transorbital approach Inside the muscle cone;
lateral wall of the orbit
+ +(< 10 %) Orbital exenteration Recurrence 8
Cranio-orbital mass R Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure;
Subdural brain tissue
+ +(< 20 %) The mass disappeared None recurrence 35
5/F Proptosis R Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 5 %) Improvement of the proptosis None recurrence 82
6/M Proptosis L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit
+ +(< 5 %) Improvement of the proptosis Recurrence 228
Proptosis;
Blindness
L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 5 %) Improvement of the proptosis None recurrence 31
7/F Proptosis R Transorbital approach Outside the muscle cone + +(< 10 %) Improvement of the proptosis None recurrence 30
8/F Proptosis; Vision loss;
Ocular movement disorder
R Transorbital approach Inside the muscle cone;
lateral wall of the orbit
+ +(< 10 %) Improvement of the proptosis Recurrence 72
Proptosis; Vision loss;
Ocular movement disorder
R Transorbital approach Inside the muscle cone;
lateral wall of the orbit
+ +(< 10 %) Improvement of the proptosis Recurrence 72
Proptosis; Vision loss;
Ocular movement disorder
R Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Improvement of the proptosis None recurrence 53
9/M Proptosis; Vision loss;
Ocular movement disorder
L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Improvement of the proptosis Recurrence 54
Proptosis; Vision loss;
Ocular movement disorder
L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Blindness Recurrence 45
10/F Proptosis; Vision loss; L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Blindness Recurrence 154
Proptosis; Blindness L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Improvement of the proptosis None recurrence 43
11/M Proptosis; Vision loss L Transfronto-orbital approach Inside the muscle cone + +(< 5 %) Improvement of the proptosis None recurrence 57
12/F Proptosis; Vision loss L Transfronto-orbital approach Inside the muscle cone + +(< 5 %) Improvement of the proptosis None recurrence 74
13/F Proptosis; Vision loss R Transorbital approach Inside the muscle cone + +(< 10 %) Improvement of the proptosis Recurrence 36
Proptosis; Vision loss;
pain
R Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus and superior orbital fissure
+ +(< 10 %) Improvement of the proptosis None recurrence 125
14/M Proptosis; Vision loss L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus
+ +(< 10 %) Improvement of the proptosis None recurrence 11
15/F Proptosis; Vision loss L Transorbital approach Inside the muscle cone; + +(< 10 %) Improvement of the proptosis and vision Recurrence 78
Proptosis; Vision loss L Transfronto-orbital approach Inside the muscle cone;
lateral wall of the orbit;
cavernous sinus
+ +(< 10 %) Improvement of the proptosis None recurrence 30
16/M Proptosis L Transorbital approach Outside the muscle cone lateral wall of the orbit + +(< 5 %) Improvement of the proptosis None recurrence 28
\